emendrixAccount

Provision history · CLP

Art. 6 · Identification and examination of available information on mixtures

Classification, Labelling and Packaging Regulation · 32008R1272 · every version of this act · on EUR-Lex (external, EUR-Lex)

3 changes recorded across 3 versions, newest first.

Follow this provision (Atom) · Watch it from CI · Watch this provision

Version in force , Modified +811 −171

Amended by Regulation (EU) 2024/2865 32024R2865 on EUR-Lex (external, EUR-Lex)

Applies from: no date changed

Explanation, written by a model and checked against the cited text

A new point (ca) was added to paragraph 1 listing data obtained from new approach methodologies as a type of information to be identified.

Paragraph 3 now also covers endocrine disruption for human health and for the environment among the hazard classes for which only substance-level information is used, adds references to sections 3.11.3.1 and 4.2.3.1 of Annex I, states explicitly that this information is used for the substances and not for the mixture itself, and extends the rule on mixture test data showing unidentified effects to also cover endocrine disruption effects.

Paragraph 4 now also covers persistency and mobility properties, PBT/vPvB and PMT/vPvM hazard classes with added Annex I section references, and likewise states that substance-level information is used and not information on the mixture itself.

Cited: Art. 6, v2 (external, EUR-Lex) · Art. 6, v1 (external, EUR-Lex)

v1 is the previous version, v2 this one.

Text from EUR-Lex, before and after

Previous version, in force 1 May 2026 02008R1272-20260501 → this version, in force 1 July 2026 02008R1272-20260701

Article 6 Identification and examination of available information on mixtures 1. Manufacturers, importers and downstream users of a mixture shall identify the relevant available information on the mixture itself or the substances contained in it for the purposes of determining whether the mixture entails a physical, health or environmental hazard as set out in Annex I, and, in particular, the following: (a) data generated in accordance with any of the methods referred to in Article 8(3) on the mixture itself or the substances contained in it; (b) epidemiological data and experience on the effects on humans for the mixture itself or the substances contained in it, such as occupational data or data from accident databases; (c) any other information generated in accordance with section 1 of Annex XI to Regulation (EC) No 1907/2006 for the mixture itself or the substances contained in it; (ca) data obtained from new approach methodologies; (d) any other information generated under internationally recognised chemical programmes for the mixture itself or the substances contained in it. The information shall relate to the forms or physical states in which the mixture is placed on the market and, when relevant, in which it can reasonably be expected to be used. 2. Subject to paragraphs 3 and 4, where the information referred to in paragraph 1 is available for the mixture itself, and the manufacturer, importer or downstream user has ascertained that information to be adequate and reliable and where applicable, scientifically valid, that manufacturer, importer or downstream user shall use that information for the purposes of the evaluation pursuant to Chapter 2 of this Title. 3. For the evaluation of mixtures pursuant to Chapter chapter 2 of this Title in relation to the germ cell mutagenicity, carcinogenicity carcinogenicity, reproductive toxicity, endocrine disruption for human health and reproductive toxicity endocrine disruption for the environment hazard classes referred to in sections 3.5.3.1, 3.6.3.1 3.6.3.1, 3.7.3.1, 3.11.3.1 and 3.7.3.1 4.2.3.1 of Annex I, the manufacturer, importer or and downstream user shall only use the relevant available information referred to in paragraph 1 for the substances in the mixture. Further, in cases where mixture and not for the mixture itself. Where the available test data on the mixture itself demonstrate germ cell mutagenic, carcinogenic or toxic to reproduction effects properties, or endocrine disruption for human health or the environment which have not been identified from the relevant available information on the individual substances, substance referred to in the first subparagraph, those data shall also be taken into account. account for the purposes of the evaluation of the mixture referred to in the first subparagraph. 4. For the evaluation of mixtures pursuant to Chapter 2 of this Title in relation to the biodegradation biodegradation, persistency, mobility and bioaccumulation properties within the hazardous to the aquatic environment environment, persistent, bioaccumulative and toxic or very persistent, very bioaccumulative properties and persistent, mobile and toxic or very persistent, very mobile properties hazard class classes referred to in sections 4.1.2.8 4.1.2.8, 4.1.2.9, 4.3.2.3.1, 4.3.2.3.2, 4.4.2.3.1 and 4.1.2.9 4.4.2.3.2 of Annex I, the manufacturer, importer or and downstream user shall only use the relevant available information referred to in paragraph 1 for the substances in the mixture. mixture and not for the mixture itself. 5. Where no or inadequate test data on the mixture itself of the kind referred to in paragraph 1 are available, the manufacturer, importer or downstream user shall use other available information on individual substances and similar tested mixtures which may also be considered relevant for the purposes of determining whether the mixture is hazardous, provided that that manufacturer, importer or downstream user has ascertained that information to be adequate and reliable for the purpose of the evaluation pursuant to Article 9(4).

Version in force , Modified

Amended by Regulation (EU) 2023/1435 32023R1435 on EUR-Lex (external, EUR-Lex)

Applies from: no date changed

Not in every listWhat this means

Found in the text, but not every source lists it — the text comparison found this change; the EU's own amendment metadata does not list it. The source that does not name it is the EU's own amendment metadata. Both are shown; neither is overruled.

Explanation, written by a model and checked against the cited text

Paragraph 3 no longer refers to endocrine disruption for human health or the environment, nor to the corresponding sections 3.11.3.1 and 4.2.3.1 of Annex I, and now covers only germ cell mutagenicity, carcinogenicity and reproductive toxicity under sections 3.5.3.1, 3.6.3.1 and 3.7.3.1.

The second subparagraph of paragraph 3 drops the reference to endocrine disruption effects and to the individual substance being addressed under the first subparagraph, referring instead only to germ cell mutagenic, carcinogenic or toxic to reproduction effects not identified from information on individual substances.

Paragraph 4 removes the references to mobility, persistent bioaccumulative and toxic, very persistent very bioaccumulative, and persistent mobile and toxic or very persistent very mobile properties along with sections 4.3.2.3.1, 4.3.2.3.2, 4.4.2.3.1 and 4.4.2.3.2, leaving only biodegradation and bioaccumulation under sections 4.1.2.8 and 4.1.2.9.

Cited: Art. 6, v1 (external, EUR-Lex) · Art. 6, v2 (external, EUR-Lex)

v1 is the previous version, v2 this one.

Text from EUR-Lex, on this version's page

Version in force , Modified

Amended by Regulation (EU) 2024/2865 32024R2865 on EUR-Lex (external, EUR-Lex)

Applies from: no date changed

Not in every listWhat this means

Found in the text, but not every source lists it — the text comparison and the amending act's instructions found this change; the EU's own amendment metadata does not list it. The source that does not name it is the EU's own amendment metadata. All are shown; none is overruled.

Explanation, written by a model and checked against the cited text

Paragraph 3 now lists endocrine disruption for human health and endocrine disruption for the environment alongside germ cell mutagenicity, carcinogenicity and reproductive toxicity, adding references to sections 3.11.3.1 and 4.2.3.1 of Annex I, and it now states that the substance-based information is to be used and not the information on the mixture itself, with the second subparagraph correspondingly extended to cover endocrine disruption effects.

Paragraph 4 adds persistency and mobility to the biodegradation and bioaccumulation properties covered, adds references to sections 4.3.2.3.1, 4.3.2.3.2, 4.4.2.3.1 and 4.4.2.3.2 of Annex I alongside the existing 4.1.2.8 and 4.1.2.9, and now also states that only substance information is to be used and not the mixture's own information.

Cited: Art. 6, v1 (external, EUR-Lex) · Art. 6, v2 (external, EUR-Lex)

v1 is the previous version, v2 this one.

Text from EUR-Lex, on this version's page